VIEW MENU
Pet Age
 

Aratana Agrees to Acquire Vet Therapeutics


December 3, 2013

Aratana Therapeutics, a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, entered into a merger agreement providing for the strategic acquisition of Vet Therapeutics, Inc., a San Diego-based company with a proprietary antibody-based biologics platform.

Under the agreement, Aratana plans to continue to advance the pipeline of high value biologic drugs, including its lymphoma franchise. Lymphoma is the most common blood cancer in dogs, accounting for an estimated 6 percent of total dog cancers, the company said.

The acquisition of Vet Therapeutics is expected to significantly accelerate Aratana’s pathway toward becoming a commercial-stage pet therapeutics company.

Share This Story On:

Enews Subscribe

Sign up for Pet Age's Weekly E-newsletter for the latest in pet business news, recalls and more.

Event Calendar

Events Calendar

« December 2016 » loading...
M T W T F S S
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
Sun 04

BarkWorld Conference & Expo

October 13 - December 16
close
Subscribe To Pet Age
Sign up for the weekly e-newsletter, print magazine and more. Sign Up